Your browser doesn't support javascript.
loading
A BCMA/CD16A bispecific innate cell engager for the treatment of multiple myeloma.
Kakiuchi-Kiyota, Satoko; Ross, Thorsten; Wallweber, Heidi Ackerly; Kiefer, James R; Schutten, Melissa M; Adedeji, Adeyemi O; Cai, Hao; Hendricks, Robert; Cohen, Sivan; Myneni, Srividya; Liu, Luna; Fullerton, Aaron; Corr, Nicholas; Yu, Lanlan; de Almeida Nagata, Denise; Zhong, Shelly; Leong, Steven R; Li, Ji; Nakamura, Rin; Sumiyoshi, Teiko; Li, Jinze; Ovacik, Ayse Meric; Zheng, Bing; Dillon, Mike; Spiess, Christoph; Wingert, Susanne; Rajkovic, Erich; Ellwanger, Kristina; Reusch, Uwe; Polson, Andrew G.
Affiliation
  • Kakiuchi-Kiyota S; Genentech Research and Early Development, San Francisco, CA, USA.
  • Ross T; Affimed GmbH, Heidelberg, Germany.
  • Wallweber HA; Genentech Research and Early Development, San Francisco, CA, USA.
  • Kiefer JR; Genentech Research and Early Development, San Francisco, CA, USA.
  • Schutten MM; Genentech Research and Early Development, San Francisco, CA, USA.
  • Adedeji AO; Genentech Research and Early Development, San Francisco, CA, USA.
  • Cai H; Genentech Research and Early Development, San Francisco, CA, USA.
  • Hendricks R; Genentech Research and Early Development, San Francisco, CA, USA.
  • Cohen S; Genentech Research and Early Development, San Francisco, CA, USA.
  • Myneni S; Genentech Research and Early Development, San Francisco, CA, USA.
  • Liu L; Genentech Research and Early Development, San Francisco, CA, USA.
  • Fullerton A; Genentech Research and Early Development, San Francisco, CA, USA.
  • Corr N; Genentech Research and Early Development, San Francisco, CA, USA.
  • Yu L; Genentech Research and Early Development, San Francisco, CA, USA.
  • de Almeida Nagata D; Genentech Research and Early Development, San Francisco, CA, USA.
  • Zhong S; Genentech Research and Early Development, San Francisco, CA, USA.
  • Leong SR; Genentech Research and Early Development, San Francisco, CA, USA.
  • Li J; Genentech Research and Early Development, San Francisco, CA, USA.
  • Nakamura R; Genentech Research and Early Development, San Francisco, CA, USA.
  • Sumiyoshi T; Genentech Research and Early Development, San Francisco, CA, USA.
  • Li J; Genentech Research and Early Development, San Francisco, CA, USA.
  • Ovacik AM; Genentech Research and Early Development, San Francisco, CA, USA.
  • Zheng B; Genentech Research and Early Development, San Francisco, CA, USA.
  • Dillon M; Genentech Research and Early Development, San Francisco, CA, USA.
  • Spiess C; Genentech Research and Early Development, San Francisco, CA, USA.
  • Wingert S; Affimed GmbH, Heidelberg, Germany.
  • Rajkovic E; Affimed GmbH, Heidelberg, Germany.
  • Ellwanger K; Affimed GmbH, Heidelberg, Germany.
  • Reusch U; Affimed GmbH, Heidelberg, Germany.
  • Polson AG; Genentech Research and Early Development, San Francisco, CA, USA. polson@gene.com.
Leukemia ; 36(4): 1006-1014, 2022 04.
Article in En | MEDLINE | ID: mdl-35001074
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antibodies, Bispecific / Multiple Myeloma Limits: Humans Language: En Journal: Leukemia Journal subject: HEMATOLOGIA / NEOPLASIAS Year: 2022 Type: Article Affiliation country: United States
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antibodies, Bispecific / Multiple Myeloma Limits: Humans Language: En Journal: Leukemia Journal subject: HEMATOLOGIA / NEOPLASIAS Year: 2022 Type: Article Affiliation country: United States